Elicera Therapeutics AB (publ) (STO:ELIC)
Sweden · Delayed Price · Currency is SEK 2.975
+0.025 (0.85%)
May 21, 2026, 12:57 PM CET
Elicera Therapeutics AB Market Cap
Elicera Therapeutics AB has a market cap or net worth of 143.18 million as of May 21, 2026. Its market cap has decreased by -30.42% in one year.
Market Cap
143.18M
Enterprise Value
125.32M
Revenue
10.64M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.98
Market Cap Chart
Since June 11, 2021, Elicera Therapeutics AB's market cap has increased from 122.65M to 143.18M, an increase of 16.74%. That is a compound annual growth rate of 3.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 20, 2026 | 143.18M | -43.49% |
| Dec 30, 2025 | 253.36M | 332.30% |
| Dec 30, 2024 | 58.61M | -35.03% |
| Dec 29, 2023 | 90.21M | 29.73% |
| Dec 30, 2022 | 69.53M | -29.98% |
| Dec 30, 2021 | 99.31M | -19.03% |
| Jun 11, 2021 | 122.65M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Initiator Pharma | 197.14M |
| Diamyd Medical AB | 185.36M |
| Nanologica AB | 164.38M |
| AlzeCure Pharma AB | 160.31M |
| Simris Group AB (PUBL) | 141.05M |
| Alligator Bioscience AB | 140.70M |
| Magle Chemoswed Holding AB | 119.55M |
| NextCell Pharma AB | 118.30M |